Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review

  • ID: 4308201
  • SWOT Analysis
  • 48 pages
  • GlobalData
  • Athersys Inc
1 of 5

FEATURED COMPANIES

  • Arena Pharmaceuticals Inc
  • Celgene Corp
  • Cytori Therapeutics Inc
  • Mesoblast Ltd
  • Pfizer Inc
  • Vericel Corp
  • MORE
Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Athersys Inc (Athersys) is a biotechnology company that discovers and develops of novel and proprietary best-in-class therapies in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product, developed for treating multiple disease indications such as cardiovascular diseases, inflammatory and immune disorders, neurological conditions and others. Its MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, bone marrow/hematopoietic stem cell transplantation, ischemic stroke and autoimmune disease. Its other program, 5HT2c agonist is used for treating obesity and other conditions such as schizophrenia. Athersys is headquartered in Cleveland, Ohio, the US.

Athersys Inc Key Recent Developments

May 10, 2018: Athersys Reports First Quarter 2018 Results
Mar 13, 2018: Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
Nov 08, 2017: Athersys Reports Third Quarter 2017 Results
Oct 11, 2017: Athersys and Nikon CeLL Innovation to Collaborate on MultiStem Commercial Manufacturing in Japan
Aug 09, 2017: Athersys Reports Second Quarter 2017 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Arena Pharmaceuticals Inc
  • Celgene Corp
  • Cytori Therapeutics Inc
  • Mesoblast Ltd
  • Pfizer Inc
  • Vericel Corp
  • MORE

Section 1 - About the Company

  • Athersys Inc - Key Facts
  • Athersys Inc - Key Employees
  • Athersys Inc - Key Employee Biographies
  • Athersys Inc - Major Products and Services
  • Athersys Inc - History
  • Athersys Inc - Company Statement
  • Athersys Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis

  • Company Overview
  • Athersys Inc - Business Description
  • Athersys Inc - Corporate Strategy
  • Athersys Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Athersys Inc - Strengths
  • Athersys Inc - Weaknesses
  • Athersys Inc - Opportunities
  • Athersys Inc - Threats
  • Athersys Inc - Key Competitors

Section 3 - Company Financial Ratios

  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Athersys Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments

  • May 10, 2018: Athersys Reports First Quarter 2018 Results
  • Mar 13, 2018: Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
  • Nov 08, 2017: Athersys Reports Third Quarter 2017 Results
  • Oct 11, 2017: Athersys and Nikon CeLL Innovation to Collaborate on MultiStem Commercial Manufacturing in Japan
  • Aug 09, 2017: Athersys Reports Second Quarter 2017 Results
  • May 09, 2017: Athersys Reports First Quarter 2017 Results
  • May 03, 2017: Athersys Partnering With MedCision on High-Volume ThawSTAR Cell Thawing Systems for Use in Clinical Trials
  • Mar 09, 2017: Athersys Reports Financial Results for Fourth Quarter, Full Year 2016

Section 6 - Appendix

  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer

List of Tables

  • Athersys Inc, Key Facts
  • Athersys Inc, Key Employees
  • Athersys Inc, Key Employee Biographies
  • Athersys Inc, Major Products and Services
  • Athersys Inc, History
  • Athersys Inc, Subsidiaries
  • Athersys Inc, Key Competitors
  • Athersys Inc, Ratios based on current share price
  • Athersys Inc, Annual Ratios
  • Athersys Inc, Interim Ratios
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Athersys Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures

  • Athersys Inc, Performance Chart (2013 - 2017)
  • Athersys Inc, Ratio Charts
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Athersys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Vericel Corp
  • Pfizer Inc
  • Mesoblast Ltd
  • Cytori Therapeutics Inc
  • Cryo-Cell International Inc
  • Celgene Corp
  • Astellas Institute for Regenerative Medicine
  • Arena Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll